NIGER, MONICA

NIGER, MONICA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 19 di 19 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 2015 F. PietrantonioP. BiondaniNIGER, MONICAGHIDINI, MICHELEBOZZARELLI, SILVIAF. De Braud + Article (author) -
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial 2019 Niger, Monicade Braud, FilippoPietrantonio, Filippo + Article (author) -
BRAF in metastatic colorectal cancer : the future starts now 2015 M. NigerI. BossiF. De BraudF. Pietrantonio + Article (author) -
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 2019 Pusceddu, SaraGhidini, MicheleCorti, FrancescaNiger, MonicaNichetti, FedericoCabiddu, Maryde Braud, FilippoPetrelli, Fausto + Article (author) -
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 2017 Vernieri, ClaudioVolpi, Chiara CostanzaNiger, MonicaValtorta, EmanueleFucà, GiovanniDi Bartolomeo, MariaDe Braud, FilippoPietrantonio, Filippo + Article (author) -
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis 2021 Pietrantonio F.Niger M.de Braud F. + Article (author) -
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 2016 F. PietrantonioC. MaggiM. NigerA. MennittoF. de Braud + Article (author) -
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 2019 Pietrantonio, FilippoRaimondi, AlessandraSartore-Bianchi, AndreaNiger, MonicaPetrelli, FaustoLongarini, RaffaellaDi Bartolomeo, Mariade Braud, Filippo + Article (author) -
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 2022 Azzollini, JacopoVingiani, AndreaAgnelli, LucaRosina, EricaDucceschi, MonikaNiger, MonicaDamian, Silviade Braud, FilippoPruneri, Giancarlo + Article (author) -
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei 2019 Raimondi, AlessandraNiger, MonicaRandon, GiovanniDe Braud, FilippoPietrantonio, Filippo + Article (author) -
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 2022 Niger, MonicaNichetti, FedericoPircher, ChiaraVingiani, AndreaAgnelli, LucaPusceddu, SaraCorti, FrancescaPrisciandaro, MicheleBini, MartaPruneri, GiancarloMazzaferro, VincenzoPietrantonio, Filippode Braud, Filippo + Article (author) -
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 2017 Pietrantonio, FilippoCotsoglou, ChristianInfante, GabrieleCoppa, JorgelinaPadovano, BarbaraMennitto, AlessiaNiger, MonicaFucà, GiovanniLazzati, SilviaGreco, GiorgioDelconte, GabrieleDe Braud, FilippoMazzaferro, VincenzoDi Bartolomeo, Maria + Article (author) -
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 2019 Randon, GiovanniFucà, GiovanniRaimondi, AlessandraPagani, FilippoPeverelli, GiorgiaNiger, MonicaPruneri, Giancarlode Braud, FilippoPietrantonio, Filippo + Article (author) -
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 2021 Brandi G.Niger M.Caputo F.Casagrande M.Nichetti F.de Braud F. + Article (author) -
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015 : a systematic review 2016 F. PietrantonioM. Niger + Article (author) -
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer : Real-World Data from the RAMoss Study 2018 M. NigerF. Pietrantonio + Article (author) -
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors 2016 E. VerzoniM. NigerF. De BraudR. Valdagni + Article (author) -
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives 2019 Corti, FrancescaNichetti, FedericoRaimondi, AlessandraNiger, MonicaPruneri, Giancarlode Braud, FilippoPusceddu, Sara + Article (author) -
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 2015 F.S. FalvellaS. CheliC. MaggiM. NigerF. RicchiniI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -